Similar articles

Abstract: Painful diabetic neuropathy (PDN) is a diabetes mellitus complication. Unfortunately, the mechanisms underlying PDN are still poorly understood. Adenosine triphosphate (ATP)-gated p2X7 receptor (P2X7R) plays a pivotal role in non-diabetic neuropathic pain, but little is known about its effects on streptozotocin (STZ)-induced peripheral neuropathy. Here, we explored whether spinal cord P2X7R was correlated with the generation of mechanical allodynia (MA) in STZ-induced type 1 diabetic neuropathy in mice. MA was assessed by measuring paw withdrawal thresholds and western blotting. Immunohistochemistry was applied to analyze the protein expression levels and localization of P2X7R. STZ-induced mice expressed increased P2X7R in the dorsal horn of the lumbar spinal cord during MA. Mice injected intrathecally with a selective antagonist of P2X7R and P2X7R knockout (KO) mice both presented attenuated progression of MA. Double-immunofluorescent labeling demonstrated that P2X7R-positive cells were mostly co-expressed with Iba1 (a microglia marker). Our results suggest that P2X7R plays an important role in the development of MA and could be used as a cellular target for treating PDN.

脊髓P2X7受体参与链脲佐菌素诱导的小鼠糖尿病早期机械痛性神经病变

[1]Bele T, Fabbretti E, 2015. P2X receptors, sensory neurons and pain. Curr Med Chem, 22(7):845-850.

[2]Berger JR, Choi D, Kaminski HJ, et al., 2013. Importance and hurdles to drug discovery for neurological disease. Ann Neurol, 74(3):441-446.

[3]Bernier LP, Ase AR, Séguéla P, 2018. P2X receptor channels in chronic pain pathways. Br J Pharmacol, 175(12):2219-2230.

[4]Burnstock G, 2014. Purinergic signalling: from discovery to current developments. Exp Physiol, 99(1):16-34.

[5]Cheng KI, Wang HC, Chuang YT, et al., 2014. Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic rats. Eur J Pain, 18(2):162-173.

[6]Chessell IP, Hatcher JP, Bountra C, et al., 2005. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain, 114(3):386-396.

[7]Deuchars SA, Atkinson L, Brooke RE, et al., 2001. Neuronal P2X₇ receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci, 21(18):7143-7152.

[8]Falk S, Schwab SD, Frøsig-Jorgensen M, et al., 2015. P2X7 receptor-mediated analgesia in cancer-induced bone pain. Neuroscience, 291:93-105.

[9]Guo XX, Wang Y, Wang K, et al., 2018. Stability of a type 2 diabetes rat model induced by high-fat diet feeding with low-dose streptozotocin injection. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 19(7):559-569.

[10]He XF, Wei JJ, Shou SY, et al., 2017. Effects of electroacupuncture at 2 and 100 Hz on rat type 2 diabetic neuropathic pain and hyperalgesia-related protein expression in the dorsal root ganglion. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18(3):239-248.

[11]Huang ZX, Lu ZJ, Ma WQ, et al., 2014. Involvement of RVM-expressed P2X7 receptor in bone cancer pain: mechanism of descending facilitation. Pain, 155(4):783-791.

[12]Illes P, Khan TM, Rubini P, 2017. Neuronal P2X7 receptors revisited: do they really exist? J Neurosci, 37(30):7049-7062.

[13]Javed S, Alam U, Malik RA, 2015. Burning through the pain: treatments for diabetic neuropathy. Diabetes Obes Metab, 17(12):1115-1125.

[14]Jiang K, Zhuang Y, Yan M, et al., 2016. Effects of riluzole on P2X7R expression in the spinal cord in rat model of neuropathic pain. Neurosci Lett, 618:127-133.

[15]Jiang TF, Hoekstra J, Heng X, et al., 2015. P2X7 receptor is critical in α-synuclein-mediated microglial NADPH oxidase activation. Neurobiol Aging, 36(7):2304-2318.

[16]Kobayashi K, Takahashi E, Miyagawa Y, et al., 2011. Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model. Neurosci Lett, 504(1):57-61.

[17]Liu SM, Zou LF, Xie JY, et al., 2016. LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X₇ receptor in dorsal root ganglia. Mol Brain, 9:44.

[18]Liu WJ, Ao QY, Guo QL, et al., 2017. miR-9 mediates CALHM1-activated ATP-P2X7R signal in painful diabetic neuropathy rats. Mol Neurobiol, 54(2):922-929.

[19]Lu WN, Albalawi F, Beckel JM, et al., 2017. The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes. J Neurochem, 141(3):436-448.

[20]Mehta N, Kaur M, Singh M, et al., 2014. Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy. Bioorg Med Chem, 22(1):54-88.

[21]Miras-Portugal MT, Sebastián-Serrano Á, de Diego García L, et al., 2017. Neuronal P2X7 receptor: involvement in neuronal physiology and pathology. J Neurosci, 37(30):7063-7072.

[22]Moore RA, Wiffen PJ, Derry S, et al., 2011. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev, 3:CD007938.

[23]Ni GL, Cui R, Shao AM, et al., 2017. Salidroside ameliorates diabetic neuropathic pain in rats by inhibiting neuroinflammation. J Mol Neurosci, 63(1):9-16.

[24]Ochi-Ishi R, Nagata K, Inoue T, et al., 2014. Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia. Mol Pain, 10:53.

[25]Pan Q, Li QM, Deng W, et al., 2018. Prevalence of and risk factors for peripheral neuropathy in Chinese patients with diabetes: a multicenter cross-sectional study. Front Endocrinol (Lausanne), 9:617.

[26]Pop-Busui R, Boulton AJM, Feldman EL, et al., 2017. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care, 40(1):136-154.

[27]Sánchez-Nogueiro J, Marín-Garcia P, Bustillo D, et al., 2014. Subcellular distribution and early signalling events of P2X7 receptors from mouse cerebellar granule neurons. Eur J Pharmacol, 744:190-202.

[28]Tsuda M, Ueno H, Kataoka A, et al., 2008. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. GLIA, 56(4):378-386.

[29]Vinik A, Emir B, Cheung R, et al., 2013. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. Clin Ther, 35(5):612-623.

[30]Wang DM, Couture R, Hong YG, 2014. Activated microglia in the spinal cord underlies diabetic neuropathic pain. Eur J Pharmacol, 728:59-66.

[31]Wu B, Peng LC, Xie JY, et al., 2017. The P2X₇ receptor in dorsal root ganglia is involved in HIV gp120-associated neuropathic pain. Brain Res Bull, 135:25-32.

[32]Yao ZY, Chen WB, Shao SS, et al., 2018. Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 19(3):183-198.

[33]Ying YL, Wei XH, Xu XB, et al., 2014. Over-expression of P2X7 receptors in spinal glial cells contributes to the development of chronic postsurgical pain induced by skin/muscle incision and retraction (SMIR) in rats. Exp Neurol, 261:836-843.

[34]Zhang PA, Xu QY, Xue L, et al., 2017. Neonatal maternal deprivation enhances presynaptic P2X7 receptor transmission in insular cortex in an adult rat model of visceral hypersensitivity. CNS Neurosci Ther, 23(2):145-154.